Innovative Bioengineered Chewing Gum Shows Remarkable Success in Reducing Oral Cancer-Linked Viruses and Bacteria
Photo: National Institute of Allergy and Infectious Diseases / Unsplash
Researchers at the University of Pennsylvania have developed a bioengineered chewing gum that successfully reduced HPV levels by 93 percent in oral samples from head and neck cancer patients. Additionally, when paired with an antimicrobial peptide, the gum successfully eliminated nearly all traces of two bacteria linked to oral cancer, offering a promising and accessible new treatment option.
Researchers at the University of Pennsylvania have developed a bioengineered chewing gum that successfully reduced HPV levels by 93 percent in oral samples from head and neck cancer patients. Additionally, when paired with an antimicrobial peptide, the gum successfully eliminated nearly all traces of two bacteria linked to oral cancer, offering a promising and accessible new treatment option.